JAZZ News and Press, Jazz Pharmaceuticals plc From 11/08/23

Jazz Pharmaceuticals plc (JAZZ) is expected to report $4.21 for Q3 2023

Jazz Pharmaceuticals and MD Anderson Announce Five-Year Collaboration to Evaluate Zanidatamab in HER2-Expressing Cancers PR Newswire DUBLIN and HOUSTON , Nov. 7, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and The University of ...

Jazz Pharmaceuticals to Report 2023 Third Quarter Financial Results on November 8, 2023 PR Newswire DUBLIN , Oct. 25, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2023 third quarter financial results on We...

2023-10-25 08:30:32 ET Palm Beach, FL – October 25, 2023 – FinancialNewsMedia.com News Commentary – The R&D for cancer vaccines has been growing in the last few years and is projected to continue through the next decade. A cancer vaccine is used to eithe...

Jazz Pharmaceuticals Presents Data Highlighting the Continued Need for Low-Sodium Treatment Option Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Real-World, Evidence-Based Approaches for Individualized Treatment in Adults with Narcolepsy at World Sleep 2023 ...

2023-10-20 13:48:29 ET More on Jazz Pharmaceuticals Jazz Pharma: Playing The High Notes With Xywav Jazz Pharmaceuticals plc (JAZZ) Q2 2023 Earnings Call Transcript Jazz Pharmaceuticals: Depressed Valuation Opens Up Potential Biggest stock movers today: Hewlet...

2023-10-20 09:13:00 ET U.S. stock index futures on Friday pointed to a lower open. Wall Street's benchmark S&P 500 ( SP500 ) gauge has fallen more than 1% so far this week, as sentiment has been weighed down by geopolitical concerns, economic data and a surge in Treasury yields....

2023-10-20 06:34:58 ET Summary CVS pulls oral medications containing decongestant phenylephrine due to lawsuits and doubts about its effectiveness. Toyota agrees to adopt Tesla's charging standard for its battery electric vehicles in North America. Jazz Pharmaceuticals explore...

2023-10-19 22:50:09 ET More on Jazz Pharmaceuticals Jazz Pharma: Playing The High Notes With Xywav Jazz Pharmaceuticals plc (JAZZ) Q2 2023 Earnings Call Transcript Jazz Pharmaceuticals: Depressed Valuation Opens Up Potential Ionis, AbbVie, Alnylam draw bullis...

Jazz Pharmaceuticals to Present Latest Advancements in Sleep Medicine at World Sleep 2023 PR Newswire Meeting presentations underscore the increased need for awareness around the cardiovascular and cardiometabolic comorbidities and modifiable risk factors associated with sleep...